Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening.
about
Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women.Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala.HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples.Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.
P2860
Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Clinical validation of Anyplex ...... for cervical cancer screening.
@en
type
label
Clinical validation of Anyplex ...... for cervical cancer screening.
@en
prefLabel
Clinical validation of Anyplex ...... for cervical cancer screening.
@en
P2093
P1476
Clinical validation of Anyplex ...... for cervical cancer screening.
@en
P2093
A T Hesselink
D A M Heideman
M C G Bleeker
M L van der Salm
P J F Snijders
P356
10.1016/J.JCV.2016.01.009
P50
P577
2016-01-15T00:00:00Z